UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

English Journal

A new biflavonoid from Solanum dulcamara L. and investigation of anti-hyperglycaemic activity of its fruit extract.

Sabudak T1, Kaya O, Cukurova E.
Natural product research.Nat Prod Res.2015 Feb;29(4):308-14. doi: 10.1080/14786419.2014.928878. Epub 2014 Sep 18.
A new biflavone, 6,2',3″,5″,4‴-pentahydroxy-3,7″-biflavone, has been isolated from the fruits of Solanum dulcamara L., in addition to two known compounds, β-sitosterol and stigmasterol. Their structures were established on the basis of UV, IR, 1D, 2D NMR and HR-ESI-MS spectroscopic methods.
PMID 25230855

Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors.

Aaboe K1, Akram S, Deacon CF, Holst JJ, Madsbad S, Krarup T.
Diabetes, obesity & metabolism.Diabetes Obes Metab.2015 Jan;17(1):74-81. doi: 10.1111/dom.12395. Epub 2014 Oct 26.
AIMS: To examine whether 12 weeks of treatment with a dipeptidyl peptidase-4 (DPP-4) inhibitor, sitagliptin, influences the insulin secretion induced by glucose, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) during a hyperglycaemic clamp in patients with ty
PMID 25243647

Diosgenin reorganizes hyperglycaemia and distorted tissue lipid profile in high fat diet-streptozotocin induced diabetic rats.

BrahmaNaidu P1, Ponmurugan P, Sabana Begum M, Mohan K, Meriga B, RavindarNaik R, Saravanan G.
Journal of the science of food and agriculture.J Sci Food Agric.2014 Dec 22. doi: 10.1002/jsfa.7057. [Epub ahead of print]
BACKGROUND: Diabesity is often connected with significant morbidity, mortality and also have a pivotal role in the development of cardiovascular diseases. Diet intervention, particularly naturaceutical antioxidants have antidiabetic potential and avert oxidative damage linked with diabetic pathogene
PMID 25530163

Predictors of hyperglycaemic individuals who do not follow up with physicians after screening in Japan: A cohort study.

Tsujimura Yuka,Takahashi Yoshimitsu,Ishizaki Tatsuro,Kuriyama Akira,Miyazaki Kikuko,Satoh Toshihiko,Ikeda Shunya,Kimura Shinya,Nakayama Takeo
Diabetes research and clinical practice 105(2), 176-184, 2014-08
… [Aims] Although people screened as being hyperglycaemic often fail to follow up with physicians for clinical assessment, epidemiologic findings on the frequency and predictors of not following up (hereafter, "no follow-up") are lacking. …
NAID 120005477232

A Review on different controllers used for Blood Glucose regulation system(<Special Issue>COMPUTATIONAL INTELLIGENCE)

KAMATH SUREKHA,GEORGE V.I.,VIDYASAGAR SUDHA
Biomedical fuzzy and human sciences : the official journal of the Biomedical Fuzzy Systems Association 16(2), 3-12, 2011-10
… In this study Hoc control is applied for the insulin delivery to prevent the hyperglycaemic levels in a type I diabetic patient. …
NAID 110009717807